Dr Ralph & Marian Falk Medical Research Tr | Foundation Profile
GrantBay analyzes IRS Form 990-PF data to help grant seekers find fit funders like Dr Ralph & Marian Falk Medical Research Tr. Data shown is extracted from Form 990-PF filings.
EIN: 36-6975534
Foundation Overview
Based in Dallas, TX, Dr Ralph & Marian Falk Medical Research Tr has awarded 266 grants totaling $79,054,569 to organizations in Rhode Island, Ohio and 12 other states across the US. Individual grants range from $18,026 to $6,977,935, with a median award of $178,200.
Latest Tax Year
2024
Total Giving (all years)
$79,054,569
Total Assets
$197,198,086
Median Grant (all grants)
$178,200
Latest Form 990-PF Snapshot
Total Grants
38
Median Grant
$175,720
% No Significant Change
-1%
(vs previous year)
Data extracted from IRS Form 990-PF filings. Last filing year:
May 2026
Foundation Intelligence
Advanced analytics and strategic insights to help nonprofit organizations assess grant opportunities and optimize their application strategies
New Applicant Friendliness
Relationship-Focused: 18%
7 of 38 recipients (18%) were new grantees. Foundation strongly favors organizations with proven track records. New partnerships develop slowly over time.
Geographic Focus
Ohio
Grants are geographically diversified with 24% in Ohio and funding distributed across 14 total locations. This foundation values broad geographic impact and diverse community partnerships. Within Ohio, funding concentrates in Cleveland (67%), Cincinnati (19%), Columbus (14%).
Funding Trajectory
+19%
Stable funding levels with 19% change over 5 years indicate consistent grant-making capacity and predictable philanthropic resources. This stability suggests reliable ongoing funding opportunities.
Program Areas
General Purposes + 3 others
Diversified giving across multiple program areas with primary emphasis on general purposes (71%). This broad approach suggests openness to various causes and innovative cross-sector solutions.
Where is The Money Going?
Loading geographic data...
Loading chart...
Loading chart...
Loading chart...
Grants & Funding
Analyzing past grantees provides valuable insights into Dr Ralph & Marian Falk Medical Research Tr's funding preferences, organizational priorities, and grant making patterns. This historical data helps potential applicants understand the foundation's strategic focus and identify successful funding approaches.
| Name | Amount | Location | Purpose | Year |
|---|---|---|---|---|
| Northwestern University | $210,398 | Evanston, IL, US | Therapy For Chronic Kidney | 2024 |
| Regents Of University Of Michigan | $175,000 | Ann Arbor, MI, US | Antibody Cns Delivery And | 2024 |
| Cleveland Clinic Foundation | $331,873 | Cleveland, OH, US | Development Of New Drug For | 2024 |
| Indiana University | $57,018 | Bloomington, IN, US | Inhibitors-peanut Specific | 2024 |
| Yale University - School Of Medicine | $348,252 | New Haven, CT, US | Making Cancer Cells Look | 2024 |
| Medical College Of Wisconsin | $334,583 | Milwaukee, WI, US | Pain Therapy - Sensory | 2024 |
| Case Western Reserve University | $175,000 | Cleveland, OH, US | Pharma Strategy To Treat | 2024 |
| University Of Minnesota | $150,426 | Minneapolis, MN, US | Severity Measure- Adductor | 2024 |
| Brown University Of Providence | $175,000 | Providence, RI, US | Repurposing Clopidogrel To | 2024 |
| Indiana University | $340,879 | Bloomington, IN, US | Pim2 Modulator-multiple | 2024 |
| Universityof Minnesota | $308,897 | Minneapolis, MN, US | T3 Therapy - Heart Failure | 2024 |
| Washington University | $175,000 | St Louis, MO, US | Stem Cell Derived Islets | 2024 |
| Ohio State University | $178,604 | Columbus, OH, US | Melanoma Onset & Recurrence | 2024 |
| Shirley Ryan Ability Lab | $175,864 | Chicago, IL, US | Restore Diaphragm - Nerve | 2024 |
| University Of Minnesota | $173,839 | Minneapolis, MN, US | Sound Waves Assessment Via | 2024 |
| University Of Minnesota | $203,837 | Minneapolis, MN, US | Systemic Bacteremia - Host | 2024 |
| University Of Minnesota | $284,681 | Minneapolis, MN, US | Optimized Mechanism Based | 2024 |
| Brown University Of Providence | $173,096 | Providence, RI, US | Gene Therapy For | 2024 |
| Yale University - School Of Medicine | $161,487 | New Haven, CT, US | Anti Vb2 Antibody Drug For | 2024 |
| Thomas Jefferson University | $333,333 | Philadelphia, PA, US | Protacs For Targeting Brca | 2024 |
| Children's Hospital Medical Center | $173,769 | Cincinnati, OH, US | Autoimmune Arthritis | 2024 |
| University Of Cincinnati | $175,000 | Cleveland, OH, US | Develop Improved Method Of | 2024 |
| Ohio State University | $151,908 | Columbus, OH, US | Develop New Therapy For | 2024 |
| Case Western Reserve University | $355,809 | Cleveland, OH, US | Immunotherapy For B Cell | 2024 |
| Indiana University | $169,910 | Bloomington, IN, US | Traumatic Brain Injury | 2024 |
| Purdue University | $257,044 | West Lafayette, IN, US | Advancing Micro Rnas As | 2024 |
| Loyola University Of Chicago | $175,000 | Chicago, IL, US | Inhibitors For Triple | 2024 |
| Northwestern University | $168,188 | Evanston, IL, US | Antibodies Treatment Of | 2024 |
| University Of Chicago | $268,735 | Chicago, IL, US | Metastic Lung Cancer Phase | 2024 |
| Michigan State University | $175,000 | East Lansing, MI, US | Develop New Odc Inhibitors | 2024 |
| Regents Of University Of Michigan | $175,000 | Ann Arbor, MI, US | Neuro-cardiac Mechanisms Of | 2024 |
| Medical College Of Wisconsin | $315,981 | Milwaukee, WI, US | New Drugs To Treat | 2024 |
| Board Regents Of University Of Wisconsin | $330,487 | Milwaukee, WI, US | Improve Diagnosis Of Breast | 2024 |
| University Of Minnesota | $176,327 | Minneapolis, MN, US | Develop Il-15 - Malaria | 2024 |
| Mayo Clinic | $175,575 | Rochester, MN, US | Cd-19 Targeted Car-msc19 In | 2024 |
| University Of Iowa | $208,319 | Iowa City, IA, US | Vascular Health Targeting | 2024 |
| Washington University | $173,717 | St Louis, MO, US | Vagus Nerve Stimulation - | 2024 |
| Cleveland Clinic Foundation | $186,955 | Cleveland, OH, US | Treatment Of Complex | 2024 |
| Brown University Of Providence | $495,146 | Providence, RI, US | Anti-malaria Drugs Targetng | 2023 |
| Childrens Hospital Medical Center | $190,000 | Cincinnati, OH, US | Lupus Nephritis Biomarkers | 2023 |
| Medical College Of Wisconsin | $377,004 | Milwaukee, WI, US | New Drugs To Treat | 2023 |
| Indiana University | $179,775 | Bloomington, IN, US | Traumatic Brain Injury | 2023 |
| Ohio State University | $197,879 | Columbus, OH, US | Develop New Therapy For | 2023 |
| University Of Chicago | $175,000 | Chicago, IL, US | Development Of Syngap1 | 2023 |
| University Of Minnesota | $173,673 | Minneapolis, MN, US | Develop Il-15 - Malaria | 2023 |
| Michigan State University | $175,000 | East Lansing, MI, US | Develop New Odc Inhibitors | 2023 |
| University Of Cincinnati | $175,000 | Cleveland, OH, US | Develop Improved Method Of | 2023 |
| University Of Cincinnati | $145,339 | Cleveland, OH, US | Targeting Sexual Cycle Of | 2023 |
| Mayo Clinic | $174,425 | Rochester, MN, US | Cd-19 Targeted Car-msc19 In | 2023 |
| Rehabilitation Institute Of Chicago | $177,796 | Chicago, IL, US | Repurpose 5-azacytidine - | 2023 |
| Thomas Jefferson University | $333,333 | Philadelphia, PA, US | Protacs For Targeting Brca | 2023 |
| Washington University | $175,216 | St Louis, MO, US | Zika Virus Genetic Arming- | 2023 |
| State University Of Iowa | $187,210 | Iowa City, IA, US | Improve Hypoxic Tumor Mgmt | 2023 |
| Cleveland Clinic Foundation | $190,000 | Cleveland, OH, US | New Weapons To Fight | 2023 |
| Cleveland Clinic Foundation | $336,255 | Cleveland, OH, US | Development Of New Drug For | 2023 |
| Thomas Jefferson University | $150,887 | Philadelphia, PA, US | Chemokine Antagonist For | 2023 |
| Indiana University | $177,271 | Bloomington, IN, US | Novel Minimally Invasive | 2023 |
| Yale University School Of Medicine | $173,017 | New Haven, CT, US | Develop Phage Therapy To | 2023 |
| Yale University School Of Medicine | $190,000 | New Haven, CT, US | Targeted Degredation Of | 2023 |
| Medical College Of Wisconsin | $318,948 | Milwaukee, WI, US | Development Of Sensory | 2023 |
| University Of Chicago | $200,685 | Chicago, IL, US | Tumor Anueploidy - | 2023 |
| Board Regents Of University Of Wisconsin | $175,000 | Milwaukee, WI, US | Diabetes Stem Cell Cure - | 2023 |
| Case Western Reserve University | $343,159 | Cleveland, OH, US | B Cell Cancer Therapy Using | 2023 |
| Case Western Reserve University | $175,000 | Cleveland, OH, US | Blocking Peptide Treatment | 2023 |
| Northwestern University | $18,026 | Evanston, IL, US | T Cell Therapy For | 2023 |
| University Of Minnesota | $168,835 | Minneapolis, MN, US | Severity Measure- Adductor | 2023 |
| Regents Of University Of Michigan | $190,000 | Ann Arbor, MI, US | Device To Predict | 2023 |
| Stanford University | $176,215 | Stanford, CA, US | Metabolic Pausing - Organ | 2023 |
| Stanford University | $163,974 | Stanford, CA, US | Novel Dna-guided Argonaute | 2023 |
| Brown University Of Providence | $175,000 | Providence, RI, US | Repurposing Clopidogrel To | 2023 |
| Indiana University | $100,000 | Bloomington, IN, US | Novel Rxr Agonist For | 2023 |
| Mayo Clinic | $181,905 | Rochester, MN, US | In Vivo Generation Of Car T | 2023 |
| Universityof Minnesota | $235,086 | Minneapolis, MN, US | Thyroid Hormone | 2023 |
| University Of Cincinnati | $497,018 | Cleveland, OH, US | Inhibitors Targeting Peanut | 2023 |
| University Of Cincinnati | $136,995 | Cleveland, OH, US | Letrozole- Novel | 2023 |
| Brown University Of Providence | $495,146 | Providence, RI, US | Anti-malaria Drugs Targetng | 2023 |
| Childrens Hospital Medical Center | $190,000 | Cincinnati, OH, US | Lupus Nephritis Biomarkers | 2023 |
| Medical College Of Wisconsin | $377,004 | Milwaukee, WI, US | New Drugs To Treat | 2023 |
| Indiana University | $179,775 | Bloomington, IN, US | Traumatic Brain Injury | 2023 |
| Ohio State University | $197,879 | Columbus, OH, US | Develop New Therapy For | 2023 |
| University Of Chicago | $175,000 | Chicago, IL, US | Development Of Syngap1 | 2023 |
| University Of Minnesota | $173,673 | Minneapolis, MN, US | Develop Il-15 - Malaria | 2023 |
| Michigan State University | $175,000 | East Lansing, MI, US | Develop New Odc Inhibitors | 2023 |
| University Of Cincinnati | $175,000 | Cleveland, OH, US | Develop Improved Method Of | 2023 |
| University Of Cincinnati | $145,339 | Cleveland, OH, US | Targeting Sexual Cycle Of | 2023 |
| Mayo Clinic | $174,425 | Rochester, MN, US | Cd-19 Targeted Car-msc19 In | 2023 |
| Rehabilitation Institute Of Chicago | $177,796 | Chicago, IL, US | Repurpose 5-azacytidine - | 2023 |
| Thomas Jefferson University | $333,333 | Philadelphia, PA, US | Protacs For Targeting Brca | 2023 |
| Washington University | $175,216 | St Louis, MO, US | Zika Virus Genetic Arming- | 2023 |
| State University Of Iowa | $187,210 | Iowa City, IA, US | Improve Hypoxic Tumor Mgmt | 2023 |
| Cleveland Clinic Foundation | $190,000 | Cleveland, OH, US | New Weapons To Fight | 2023 |
| Cleveland Clinic Foundation | $336,255 | Cleveland, OH, US | Development Of New Drug For | 2023 |
| Thomas Jefferson University | $150,887 | Philadelphia, PA, US | Chemokine Antagonist For | 2023 |
| Indiana University | $177,271 | Bloomington, IN, US | Novel Minimally Invasive | 2023 |
| Yale University School Of Medicine | $173,017 | New Haven, CT, US | Develop Phage Therapy To | 2023 |
| Yale University School Of Medicine | $190,000 | New Haven, CT, US | Targeted Degredation Of | 2023 |
| Medical College Of Wisconsin | $318,948 | Milwaukee, WI, US | Development Of Sensory | 2023 |
| University Of Chicago | $200,685 | Chicago, IL, US | Tumor Anueploidy - | 2023 |
| Board Regents Of University Of Wisconsin | $175,000 | Milwaukee, WI, US | Diabetes Stem Cell Cure - | 2023 |
| Case Western Reserve University | $343,159 | Cleveland, OH, US | B Cell Cancer Therapy Using | 2023 |
| Case Western Reserve University | $175,000 | Cleveland, OH, US | Blocking Peptide Treatment | 2023 |
| Northwestern University | $18,026 | Evanston, IL, US | T Cell Therapy For | 2023 |
| University Of Minnesota | $168,835 | Minneapolis, MN, US | Severity Measure- Adductor | 2023 |
| Regents Of University Of Michigan | $190,000 | Ann Arbor, MI, US | Device To Predict | 2023 |
| Stanford University | $176,215 | Stanford, CA, US | Metabolic Pausing - Organ | 2023 |
| Stanford University | $163,974 | Stanford, CA, US | Novel Dna-guided Argonaute | 2023 |
| Brown University Of Providence | $175,000 | Providence, RI, US | Repurposing Clopidogrel To | 2023 |
| Indiana University | $100,000 | Bloomington, IN, US | Novel Rxr Agonist For | 2023 |
| Mayo Clinic | $181,905 | Rochester, MN, US | In Vivo Generation Of Car T | 2023 |
| Universityof Minnesota | $235,086 | Minneapolis, MN, US | Thyroid Hormone | 2023 |
| University Of Cincinnati | $497,018 | Cleveland, OH, US | Inhibitors Targeting Peanut | 2023 |
| University Of Cincinnati | $136,995 | Cleveland, OH, US | Letrozole- Novel | 2023 |
| Brown University Of Providence | $504,854 | Providence, RI, US | Anti-malaria Drugs Targetng | 2022 |
| Case Western Reserve University | $93,494 | Cleveland, OH, US | Immunotherapy For B Cell | 2022 |
| Childrens Hospital Medical Center | $200,000 | Cincinnati, OH, US | Lupus Nephritis Biomarkers | 2022 |
| Medical College Of Wisconsin | $74,113 | Milwaukee, WI, US | New Drugs To Treat | 2022 |
| Cleveland Clinic Foundation | $100,000 | Cleveland, OH, US | Glioblastoma Anti-cancer | 2022 |
| Board Regents Of University Of Wisconsin | $190,000 | Milwaukee, WI, US | Nanoparticles Target | 2022 |
| Indiana University | $445,923 | Bloomington, IN, US | Targeting Peanut-specific | 2022 |
| Northwestern University | $100,000 | Evanstone, IL, US | Neoantigen Inducers As | 2022 |
| Regents Of University Of Michigan | $100,000 | Ann Arbor, MI, US | Decoding The Druggable | 2022 |
| Ohio State University | $94,051 | Columbus, OH, US | Optimizing Btk Inhibitor | 2022 |
| Stanford University - Development Services | $190,000 | Redwood City, CA, US | Novel Therapies - Major | 2022 |
| University Of Iowa Research Foundation | $94,489 | Iowa City, IA, US | Piezoelectric Immunosensor | 2022 |
| University Of Chicago | $175,000 | Chicago, IL, US | Development Of Syngap1 | 2022 |
| University Of Minnesota | $100,000 | Minneapolis, MN, US | Electrical Brain Circuit | 2022 |
| Rush University Medical Center | $99,458 | Chicago, IL, US | Anti-hiv Antibodies To | 2022 |
| Michigan State University | $100,000 | East Lansing, MI, US | Mmpl3 Inhibitors - | 2022 |
| Yale University School Of Medicine | $100,000 | New Haven, CT, US | Bedside Liquid Biopsy For | 2022 |
| Kumc Research Institute | $100,000 | Kansas City, KS, US | Eulicidating Roles Related | 2022 |
| University Of Cincinnati | $211,322 | Cleveland, OH, US | Studies For Repurposing | 2022 |
| University Of Cincinnati | $204,619 | Cleveland, OH, US | Targeting Sexual Cycle Of | 2022 |
| Mayo Clinic | $168,095 | Minneapolis, MN, US | In Vivo Generation - Car T | 2022 |
| Rehabilitation Institute Of Chicago | $171,431 | Chicago, IL, US | Repurpose 5-azacytidine - | 2022 |
| Thomas Jefferson University | $333,333 | Philadelphia, PA, US | Protacs For Targeting Brca | 2022 |
| Washington University | $174,784 | St Louis, MO, US | Zika Virus Genetic Arming- | 2022 |
| State University Of Iowa | $156,013 | Iowa City, IA, US | Improve Hypoxic Tumor Mgmt | 2022 |
| Cleveland Clinic Foundation | $200,000 | Cleveland, OH, US | New Weapons To Fight | 2022 |
| Cleveland Clinic Foundation | $99,684 | Cleveland, OH, US | Development Of New Drug For | 2022 |
| Thomas Jefferson University | $196,613 | Philadelphia, PA, US | Chemokine Antagonist For | 2022 |
| Indiana University | $172,729 | Bloomington, IN, US | Novel Minimally Invasive | 2022 |
| Yale University School Of Medicine | $175,188 | New Haven, CT, US | Develop Phage Therapy To | 2022 |
| Yale University School Of Medicine | $200,000 | New Haven, CT, US | Targeted Degredation Of | 2022 |
| Medical College Of Wisconsin Sen Neuron | $346,469 | Milwaukee, WI, US | Development Of Sensory | 2022 |
| University Of Chicago | $148,325 | Chicago, IL, US | Tumor Anueploidy - | 2022 |
| Yale University School Of Medicine | $100,000 | New Haven, CT, US | Develop Antigen-mimicry | 2022 |
| Board Regents Of University Of Wisconsin | $175,000 | Milwaukee, WI, US | Diabetes Stem Cell Cure - | 2022 |
| Case Western Reserve University | $301,032 | Cleveland, OH, US | B Cell Cancer Therapy Using | 2022 |
| Case Western Reserve University | $175,000 | Cleveland, OH, US | Blocking Peptide Treatment | 2022 |
| Childrens Hospital Medical Center | $190,000 | Cincinnati, OH, US | Develop Human Liver | 2022 |
| Childrens Hospital Medical Center | $100,000 | Cincinnati, OH, US | Early Outcome Indicators | 2022 |
| Northwestern University | $331,974 | Evanstone, IL, US | T Cell Thearpy For | 2022 |
| University Of Minnesota | $114,914 | Minneapolis, MN, US | Aerosolized Thyroid Hormone | 2022 |
| Regents Of University Of Michigan | $200,000 | Ann Arbor, MI, US | Device To Predict | 2022 |
| Stanford University - Development Services | $173,785 | Redwood City, CA, US | Metabolic Pausing - Organ | 2022 |
| Stanford University - Development Services | $100,000 | Redwood City, CA, US | Biomarkers For Immune | 2022 |
| Stanford University - Development Services | $159,101 | Redwood City, CA, US | Novel Dna-guided Argonaute | 2022 |
| University Of Chicago | $100,000 | Chicago, IL, US | Statistical Design Of | 2022 |
| Brown University Of Providence | $504,854 | Providence, RI, US | Anti-malaria Drugs Targetng | 2022 |
| Case Western Reserve University | $93,494 | Cleveland, OH, US | Immunotherapy For B Cell | 2022 |
| Childrens Hospital Medical Center | $200,000 | Cincinnati, OH, US | Lupus Nephritis Biomarkers | 2022 |
| Medical College Of Wisconsin | $74,113 | Milwaukee, WI, US | New Drugs To Treat | 2022 |
| Cleveland Clinic Foundation | $100,000 | Cleveland, OH, US | Glioblastoma Anti-cancer | 2022 |
| Board Regents Of University Of Wisconsin | $190,000 | Milwaukee, WI, US | Nanoparticles Target | 2022 |
| Indiana University | $445,923 | Bloomington, IN, US | Targeting Peanut-specific | 2022 |
| Northwestern University | $100,000 | Evanstone, IL, US | Neoantigen Inducers As | 2022 |
| Regents Of University Of Michigan | $100,000 | Ann Arbor, MI, US | Decoding The Druggable | 2022 |
| Ohio State University | $94,051 | Columbus, OH, US | Optimizing Btk Inhibitor | 2022 |
| Stanford University - Development Services | $190,000 | Redwood City, CA, US | Novel Therapies - Major | 2022 |
| University Of Iowa Research Foundation | $94,489 | Iowa City, IA, US | Piezoelectric Immunosensor | 2022 |
| University Of Chicago | $175,000 | Chicago, IL, US | Development Of Syngap1 | 2022 |
| University Of Minnesota | $100,000 | Minneapolis, MN, US | Electrical Brain Circuit | 2022 |
| Rush University Medical Center | $99,458 | Chicago, IL, US | Anti-hiv Antibodies To | 2022 |
| Michigan State University | $100,000 | East Lansing, MI, US | Mmpl3 Inhibitors - | 2022 |
| Yale University School Of Medicine | $100,000 | New Haven, CT, US | Bedside Liquid Biopsy For | 2022 |
| Kumc Research Institute | $100,000 | Kansas City, KS, US | Eulicidating Roles Related | 2022 |
| University Of Cincinnati | $211,322 | Cleveland, OH, US | Studies For Repurposing | 2022 |
| University Of Cincinnati | $204,619 | Cleveland, OH, US | Targeting Sexual Cycle Of | 2022 |
| Mayo Clinic | $168,095 | Minneapolis, MN, US | In Vivo Generation - Car T | 2022 |
| Rehabilitation Institute Of Chicago | $171,431 | Chicago, IL, US | Repurpose 5-azacytidine - | 2022 |
| Thomas Jefferson University | $333,333 | Philadelphia, PA, US | Protacs For Targeting Brca | 2022 |
| Washington University | $174,784 | St Louis, MO, US | Zika Virus Genetic Arming- | 2022 |
| State University Of Iowa | $156,013 | Iowa City, IA, US | Improve Hypoxic Tumor Mgmt | 2022 |
| Cleveland Clinic Foundation | $200,000 | Cleveland, OH, US | New Weapons To Fight | 2022 |
| Cleveland Clinic Foundation | $99,684 | Cleveland, OH, US | Development Of New Drug For | 2022 |
| Thomas Jefferson University | $196,613 | Philadelphia, PA, US | Chemokine Antagonist For | 2022 |
| Indiana University | $172,729 | Bloomington, IN, US | Novel Minimally Invasive | 2022 |
| Yale University School Of Medicine | $175,188 | New Haven, CT, US | Develop Phage Therapy To | 2022 |
| Yale University School Of Medicine | $200,000 | New Haven, CT, US | Targeted Degredation Of | 2022 |
| Medical College Of Wisconsin Sen Neuron | $346,469 | Milwaukee, WI, US | Development Of Sensory | 2022 |
| University Of Chicago | $148,325 | Chicago, IL, US | Tumor Anueploidy - | 2022 |
| Yale University School Of Medicine | $100,000 | New Haven, CT, US | Develop Antigen-mimicry | 2022 |
| Board Regents Of University Of Wisconsin | $175,000 | Milwaukee, WI, US | Diabetes Stem Cell Cure - | 2022 |
| Case Western Reserve University | $301,032 | Cleveland, OH, US | B Cell Cancer Therapy Using | 2022 |
| Case Western Reserve University | $175,000 | Cleveland, OH, US | Blocking Peptide Treatment | 2022 |
| Childrens Hospital Medical Center | $190,000 | Cincinnati, OH, US | Develop Human Liver | 2022 |
| Childrens Hospital Medical Center | $100,000 | Cincinnati, OH, US | Early Outcome Indicators | 2022 |
| Northwestern University | $331,974 | Evanstone, IL, US | T Cell Thearpy For | 2022 |
| University Of Minnesota | $114,914 | Minneapolis, MN, US | Aerosolized Thyroid Hormone | 2022 |
| Regents Of University Of Michigan | $200,000 | Ann Arbor, MI, US | Device To Predict | 2022 |
| Stanford University - Development Services | $173,785 | Redwood City, CA, US | Metabolic Pausing - Organ | 2022 |
| Stanford University - Development Services | $100,000 | Redwood City, CA, US | Biomarkers For Immune | 2022 |
| Stanford University - Development Services | $159,101 | Redwood City, CA, US | Novel Dna-guided Argonaute | 2022 |
| University Of Chicago | $100,000 | Chicago, IL, US | Statistical Design Of | 2022 |
| Brown University Of Providence 9998 | $60,000 | Providence, RI, US | Anti-malaria Drugs Targetng | 2021 |
| Case Western Reserve University | $260,000 | Cleveland, OH, US | Immunotherapy For B Cell | 2021 |
| Childrens Hospital Medical Center | $1,130,000 | Cincinnati, OH, US | Research For Parkinsons, | 2021 |
| Medical College Of Wisconsin | $1,179,871 | Milwaukee, WI, US | Research For Chronic Pain; | 2021 |
| Board Of Trustees U Of Illinois | $60,000 | Chicago, IL, US | Alzheimers Disease | 2021 |
| Cleveland Clinic Foundation | $1,070,000 | Cleveland, OH, US | Glioblastoma Treatments & | 2021 |
| Board Regents Of U Of Wisconsin | $59,999 | Milwaukee, WI, US | Immunotherapy Triple | 2021 |
| Indiana University | $320,000 | Detroit, MI, US | Targeting Peanut-specific | 2021 |
| Northwestern University | $200,000 | Evanstone, IL, US | Neoantigen Inducers As | 2021 |
| Regents Of University Of Michigan | $869,930 | Pittsburgh, PA, US | Device To Predict | 2021 |
| Ohio State University | $200,000 | Columbus, OH, US | Optimizingn Btk Inhibitor | 2021 |
| Stanford University | $460,000 | Menlo Park, CA, US | Biomarkers For Immune | 2021 |
| University Of Iowa Research Foundation | $200,000 | Iowa City, IA, US | Piezoelectric Immunosensor | 2021 |
| University Of Chicago | $200,000 | Chicago, IL, US | Instatistical Design Of | 2021 |
| Regents Of The Univ Of Minnesota | $200,000 | Minneapolis, MN, US | Electrical Brain Circuit | 2021 |
| Rush University Medical Center | $200,000 | Chicago, IL, US | Anti-hiv Antibodies To | 2021 |
| Michigan State University | $400,000 | East Lansing, MI, US | Novel Rxr Agonist For | 2021 |
| Yale University School Of Medicine | $1,070,000 | New Haven, CT, US | Develope Cancer Vaccines; | 2021 |
| Kumc Ri | $200,000 | Kansas City, KS, US | Eulicidating The Role Of | 2021 |
| University Of Cincinnati | $60,000 | Cleveland, ND, US | Humanized Antibody | 2021 |
| Brown University Of Providence 9998 | $60,000 | Providence, RI, US | Anti-malaria Drugs Targetng | 2021 |
| Case Western Reserve University | $260,000 | Cleveland, OH, US | Immunotherapy For B Cell | 2021 |
| Childrens Hospital Medical Center | $1,130,000 | Cincinnati, OH, US | Research For Parkinsons, | 2021 |
| Medical College Of Wisconsin | $1,179,871 | Milwaukee, WI, US | Research For Chronic Pain; | 2021 |
| Board Of Trustees U Of Illinois | $60,000 | Chicago, IL, US | Alzheimers Disease | 2021 |
| Cleveland Clinic Foundation | $1,070,000 | Cleveland, OH, US | Glioblastoma Treatments & | 2021 |
| Board Regents Of U Of Wisconsin | $59,999 | Milwaukee, WI, US | Immunotherapy Triple | 2021 |
| Indiana University | $320,000 | Detroit, MI, US | Targeting Peanut-specific | 2021 |
| Northwestern University | $200,000 | Evanstone, IL, US | Neoantigen Inducers As | 2021 |
| Regents Of University Of Michigan | $869,930 | Pittsburgh, PA, US | Device To Predict | 2021 |
| Ohio State University | $200,000 | Columbus, OH, US | Optimizingn Btk Inhibitor | 2021 |
| Stanford University | $460,000 | Menlo Park, CA, US | Biomarkers For Immune | 2021 |
| University Of Iowa Research Foundation | $200,000 | Iowa City, IA, US | Piezoelectric Immunosensor | 2021 |
| University Of Chicago | $200,000 | Chicago, IL, US | Instatistical Design Of | 2021 |
| Regents Of The Univ Of Minnesota | $200,000 | Minneapolis, MN, US | Electrical Brain Circuit | 2021 |
| Rush University Medical Center | $200,000 | Chicago, IL, US | Anti-hiv Antibodies To | 2021 |
| Michigan State University | $400,000 | East Lansing, MI, US | Novel Rxr Agonist For | 2021 |
| Yale University School Of Medicine | $1,070,000 | New Haven, CT, US | Develope Cancer Vaccines; | 2021 |
| Kumc Ri | $200,000 | Kansas City, KS, US | Eulicidating The Role Of | 2021 |
| University Of Cincinnati | $60,000 | Cleveland, ND, US | Humanized Antibody | 2021 |
| Brown University Of Providence 9998 | $60,000 | Providence, RI, US | Anti-malaria Drugs Targetng | 2021 |
| Case Western Reserve University | $260,000 | Cleveland, OH, US | Immunotherapy For B Cell | 2021 |
| Childrens Hospital Medical Center | $1,130,000 | Cincinnati, OH, US | Research For Parkinsons, | 2021 |
| Medical College Of Wisconsin | $1,179,871 | Milwaukee, WI, US | Research For Chronic Pain; | 2021 |
| Board Of Trustees U Of Illinois | $60,000 | Chicago, IL, US | Alzheimers Disease | 2021 |
| Cleveland Clinic Foundation | $1,070,000 | Cleveland, OH, US | Glioblastoma Treatments & | 2021 |
| Board Regents Of U Of Wisconsin | $59,999 | Milwaukee, WI, US | Immunotherapy Triple | 2021 |
| Indiana University | $320,000 | Detroit, MI, US | Targeting Peanut-specific | 2021 |
| Northwestern University | $200,000 | Evanstone, IL, US | Neoantigen Inducers As | 2021 |
| Regents Of University Of Michigan | $869,930 | Pittsburgh, PA, US | Device To Predict | 2021 |
| Ohio State University | $200,000 | Columbus, OH, US | Optimizingn Btk Inhibitor | 2021 |
| Stanford University | $460,000 | Menlo Park, CA, US | Biomarkers For Immune | 2021 |
| University Of Iowa Research Foundation | $200,000 | Iowa City, IA, US | Piezoelectric Immunosensor | 2021 |
| University Of Chicago | $200,000 | Chicago, IL, US | Instatistical Design Of | 2021 |
| Regents Of The Univ Of Minnesota | $200,000 | Minneapolis, MN, US | Electrical Brain Circuit | 2021 |
| Rush University Medical Center | $200,000 | Chicago, IL, US | Anti-hiv Antibodies To | 2021 |
| Michigan State University | $400,000 | East Lansing, MI, US | Novel Rxr Agonist For | 2021 |
| Yale University School Of Medicine | $1,070,000 | New Haven, CT, US | Develope Cancer Vaccines; | 2021 |
| Kumc Ri | $200,000 | Kansas City, KS, US | Eulicidating The Role Of | 2021 |
| University Of Cincinnati | $60,000 | Cleveland, ND, US | Humanized Antibody | 2021 |
| See Attached | $6,905,713 | See Attached, RI, US | Unrestricted General | 2020 |
| See Attached | $6,977,935 | See Attached, RI, US | Unrestricted General | 2019 |
Foundations Similar to Dr Ralph & Marian Falk Medical Research Tr
Discover 5 foundations with comparable assets ($145,359,664-$215,168,243), similar grant patterns, and geographic focus in TX that may also align with your organization's funding needs and grant seeking strategy.
| Foundation Name | Total Assets | Typical Grant Size | Service Area | Similarity Match |
|---|---|---|---|---|
|
Sarah Campbell Blaffer Foundation
EIN: 74-6065234 | 1 grants awarded |
$213,638,120
(≈ Similar) |
$171,683
median grant |
Houston, TX
Same state |
|
|
Health Foundation Of East Texas
EIN: 75-2695524 | 52 grants awarded |
$215,168,243
(≈ Similar) |
$100,000
median grant |
Tyler, TX
Same state |
|
|
Toyota Usa Foundation
EIN: 95-3255038 | 140 grants awarded |
$149,670,680
(↓ Smaller) |
$200,000
median grant |
Plano, TX
Same state |
|
|
Barbara Kauffman Welder Private
EIN: 88-3695192 | 9 grants awarded |
$146,372,961
(↓ Smaller) |
$250,000
median grant |
Victoria, TX
Same state |
|
|
John R & Greli N Less Charitable Trust
EIN: 86-2643196 | 314 grants awarded |
$145,359,664
(↓ Smaller) |
$100,000
median grant |
San Antonio, TX
Same state |
|
Related Foundation Resources in TX:
Contact Information
Official contact details for Dr Ralph & Marian Falk Medical Research Tr as registered with the IRS. These details are essential for grant applications, correspondence, and due diligence processes.
| EIN | 36-6975534 |
| Website | N/A |
| Address | PO BOX 653067 Dallas, TX 75265-3067 |
Key People (1)
Board members, trustees, and key staff who oversee Dr Ralph & Marian Falk Medical Research Tr's grant making decisions and strategic direction. Understanding leadership composition can provide insights into foundation priorities and potential networking opportunities.
| Trustee | Bank Of America N A |
|---|
Forms 990-PF
IRS Form 990-PF filings provide comprehensive financial information, grant details, and operational data. These documents are essential resources for understanding foundation capacity, giving patterns, and strategic priorities.
Form 990-PF Research Tips
- Review Part XV for detailed grant recipient information and funding purposes
- Check Part I for total assets, annual giving amounts, and payout requirements
- Examine Part VIII for key personnel compensation and board structure
- Look for trends across multiple years to understand giving patterns
About This Foundation Profile
This comprehensive foundation profile for Dr Ralph & Marian Falk Medical Research Tr is powered by Grant Bay's advanced foundation research platform. Our system analyzes IRS Form 990-PF filings, grant histories, and philanthropic patterns to provide nonprofit organizations with actionable intelligence for grant seeking success.
Data Sources & Accuracy
All information is derived from official IRS filings and public records. Grant Bay processes thousands of Form 990-PF documents to extract grant details, financial data, and organizational information. Data accuracy depends on foundation reporting quality and IRS filing completeness.
Research Applications
Use this profile for prospect research, grant strategy development, application preparation, and relationship building. Combine this data with additional research on foundation priorities, application processes, and board member backgrounds for comprehensive grant seeking strategies.
Data Currency: Last updated
May 2026
based on IRS Form 990-PF filings. Foundation information reflects most recent available tax year data.